Prashant Khirsariya

459 total citations
15 papers, 319 citations indexed

About

Prashant Khirsariya is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Prashant Khirsariya has authored 15 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Prashant Khirsariya's work include Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers) and Chemical Synthesis and Analysis (2 papers). Prashant Khirsariya is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers) and Chemical Synthesis and Analysis (2 papers). Prashant Khirsariya collaborates with scholars based in Czechia, Germany and Austria. Prashant Khirsariya's co-authors include Kamil Paruch, Lumír Krejčí, Caroline C. Friedel, Dalibor Blažek, Michael Kluge, Jan Oppelt, Koen Bartholomeeusen, Zbyněk Prokop, Jiřı́ Damborský and Radka Chaloupková and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Prashant Khirsariya

14 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Prashant Khirsariya Czechia	11	186	79	79	37	37	15	319
Andreas Naschberger Austria	11	320 1.7×	26 0.3×	19 0.2×	25 0.7×	20 0.5×	22	449
Federico Medda United States	14	242 1.3×	300 3.8×	50 0.6×	10 0.3×	3 0.1×	21	613
Pauline Bourbon United States	9	137 0.7×	97 1.2×	15 0.2×	20 0.5×	6 0.2×	12	339
Chennagiri R. Pandit United States	9	155 0.8×	145 1.8×	70 0.9×	31 0.8×	6 0.2×	16	319
Dušan Ružić Serbia	11	235 1.3×	114 1.4×	56 0.7×	37 1.0×	2 0.1×	24	366
Xiucong Bao Hong Kong	12	618 3.3×	118 1.5×	120 1.5×	9 0.2×	10 0.3×	19	825
Lawrence Andrade United States	6	232 1.2×	45 0.6×	56 0.7×	14 0.4×	3 0.1×	10	344
Prashi Jain United States	13	180 1.0×	129 1.6×	49 0.6×	25 0.7×		22	342
Harshal Khanwalkar France	12	212 1.1×	105 1.3×	56 0.7×	21 0.6×	1 0.0×	14	346

Countries citing papers authored by Prashant Khirsariya

Since Specialization

Citations

This map shows the geographic impact of Prashant Khirsariya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashant Khirsariya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashant Khirsariya more than expected).

Fields of papers citing papers by Prashant Khirsariya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prashant Khirsariya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashant Khirsariya. The network helps show where Prashant Khirsariya may publish in the future.

Co-authorship network of co-authors of Prashant Khirsariya

This figure shows the co-authorship network connecting the top 25 collaborators of Prashant Khirsariya. A scholar is included among the top collaborators of Prashant Khirsariya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prashant Khirsariya. Prashant Khirsariya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Hegedűsová, Eva, David Potěšil, Prashant Khirsariya, et al.. (2025). CDK7–CDK11 axis in spliceosome regulation and pre-mRNA splicing. Nucleic Acids Research. 53(22).

2.

Němec, Václav, Prashant Khirsariya, Pavlína Janovská, et al.. (2023). Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity. Angewandte Chemie. 135(11). 1 indexed citations

3.

Němec, Václav, Prashant Khirsariya, Pavlína Janovská, et al.. (2023). Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity. Angewandte Chemie International Edition. 62(11). e202217532–e202217532. 3 indexed citations

4.

Cunningham, Michael J., D. J. Vidyadhara, Emma M. Bonniwell, et al.. (2022). Pharmacological Mechanism of the Non-hallucinogenic 5-HT_2A Agonist Ariadne and Analogs. ACS Chemical Neuroscience. 14(1). 119–135. 43 indexed citations

5.

Khirsariya, Prashant, et al.. (2022). Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides. Journal of Medicinal Chemistry. 65(7). 5701–5723. 10 indexed citations

6.

Mik, Václav, Barbora Lišková, Gabriel González, et al.. (2021). Cytoprotective activities of kinetin purine isosteres. Bioorganic & Medicinal Chemistry. 33. 115993–115993. 7 indexed citations

7.

Drápela, Stanislav, Prashant Khirsariya, Wytske M. van Weerden, et al.. (2020). The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe. Molecular Oncology. 14(10). 2487–2503. 19 indexed citations

8.

Khirsariya, Prashant, Marek Borský, Jan Verner, et al.. (2019). Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells. Haematologica. 104(12). 2443–2455. 22 indexed citations

9.

Kluge, Michael, Koen Bartholomeeusen, Jan Oppelt, et al.. (2019). CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes. EMBO Reports. 20(9). e47592–e47592. 72 indexed citations

10.

Khirsariya, Prashant, et al.. (2018). Preparation of 3,4-Substituted-5-Aminopyrazoles and 4-Substituted-2-Aminothiazoles. The Journal of Organic Chemistry. 83(24). 15380–15405. 19 indexed citations

11.

Marques, Sérgio M., Prashant Khirsariya, Kamil Paruch, et al.. (2018). Impact of the access tunnel engineering on catalysis is strictly ligand‐specific. FEBS Journal. 285(8). 1456–1476. 57 indexed citations

12.

Paruch, Kamil, Prashant Khirsariya, Karel Souček, et al.. (2017). Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells. Neoplasia. 19(10). 830–841. 26 indexed citations

13.

Maier, Lukáš, et al.. (2017). Diastereoselective Flexible Synthesis of Carbocyclic C-Nucleosides. The Journal of Organic Chemistry. 82(7). 3382–3402. 10 indexed citations

14.

Khirsariya, Prashant, Radek Jorda, Vladimı́r Kryštof, et al.. (2017). Structural Basis of the Interaction of Cyclin‐Dependent Kinase 2 with Roscovitine and Its Analogues Having Bioisosteric Central Heterocycles. ChemPhysChem. 18(7). 785–795. 15 indexed citations

15.

Doshi, Hiren, Sampark S. Thakkar, Prashant Khirsariya, Mukund Chandra Thakur, & Arabinda Ray. (2014). 6-Tosyl-4,5,6,7-Tetrahydrothieno[2,3-c]Pyridine-3-Carboxamide Analogues: Synthesis, Characterization, MO Calculation, and Antibacterial Activity. Applied Biochemistry and Biotechnology. 175(3). 1700–1709. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact